Definium Therapeutics, Inc. Investment Income, Interest and Dividend
Definium Therapeutics, Inc. (DFTX) reported Investment Income, Interest and Dividend of $3.59 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterestAndDividend · last filed 2026-08-06
- Definium Therapeutics, Inc. investment income, interest and dividend for the quarter ending 2026-06-30 was $3.59M, a 29.31% increase year-over-year.
- Definium Therapeutics, Inc. investment income, interest and dividend for the quarter ending 2026-03-31 was $3.46M, a 42.09% increase year-over-year.
- Definium Therapeutics, Inc. investment income, interest and dividend for the quarter ending 2025-12-31 was $3.49M, a 6.47% increase year-over-year.
- Definium Therapeutics, Inc. investment income, interest and dividend for the quarter ending 2025-09-30 was $2.26M, a 35.50% decline year-over-year.
- Definium Therapeutics, Inc. investment income, interest and dividend for fiscal 2025 was $10.96M, a 5.17% decline from fiscal 2024.
- Definium Therapeutics, Inc. investment income, interest and dividend for fiscal 2024 was $11.56M, a 106.98% increase from fiscal 2023.
- Definium Therapeutics, Inc. investment income, interest and dividend for fiscal 2023 was $5.58M.
| Period end | Investment Income, Interest and Dividend 3 month | Investment Income, Interest and Dividend 6 month | Investment Income, Interest and Dividend 9 month | Investment Income, Interest and Dividend 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.59M 10-Q · filed 2026-08-06 | $7.04M 10-Q · filed 2026-08-06 | $10.54M derived: sum of 3 quarters · filed 2026-08-06 | $12.80M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $3.46M 10-Q · filed 2026-05-07 | $6.95M derived: sum of 2 quarters · filed 2026-05-07 | $9.21M derived: sum of 3 quarters · filed 2026-05-07 | $11.98M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $3.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $5.75M derived: sum of 2 quarters · filed 2026-02-26 | $8.53M derived: sum of 3 quarters · filed 2026-08-06 | $10.96M 10-K · filed 2026-02-26 |
| 2025-09-30 | $2.26M 10-Q · filed 2025-11-06 | $5.04M derived: sum of 2 quarters · filed 2026-08-06 | $7.47M 10-Q · filed 2025-11-06 | $10.75M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $2.77M 10-Q · filed 2026-08-06 | $5.21M 10-Q · filed 2026-08-06 | $8.49M derived: sum of 3 quarters · filed 2026-08-06 | $11.99M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $2.43M 10-Q · filed 2026-05-07 | $5.71M derived: sum of 2 quarters · filed 2026-05-07 | $9.22M derived: sum of 3 quarters · filed 2026-05-07 | $12.34M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $3.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $6.79M derived: sum of 2 quarters · filed 2026-02-26 | $9.90M derived: sum of 3 quarters · filed 2026-02-26 | $11.56M 10-K · filed 2026-02-26 |
| 2024-09-30 | $3.51M 10-Q · filed 2025-11-06 | $6.62M derived: sum of 2 quarters · filed 2025-11-06 | $8.28M 10-Q · filed 2025-11-06 | $9.62M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $3.12M 10-Q · filed 2025-07-31 | $4.77M 10-Q · filed 2025-07-31 | $6.12M derived: sum of 3 quarters · filed 2025-07-31 | $7.61M derived: sum of 4 quarters · filed 2025-07-31 |
| 2024-03-31 | $1.66M 10-Q · filed 2025-05-08 | $3.00M derived: sum of 2 quarters · filed 2025-05-08 | $4.49M derived: sum of 3 quarters · filed 2025-05-08 | $5.88M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $2.83M derived: sum of 2 quarters · filed 2025-03-06 | $4.22M derived: sum of 3 quarters · filed 2025-03-06 | $5.58M 10-K · filed 2025-03-06 |
| 2023-09-30 | $1.49M 10-Q · filed 2024-11-07 | $2.88M derived: sum of 2 quarters · filed 2024-11-07 | $4.24M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $1.39M 10-Q · filed 2024-08-13 | $2.75M 10-Q · filed 2024-08-13 | ||
| 2023-03-31 | $1.36M 10-Q · filed 2024-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cronos Group Inc. (CRON) | $1.223B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B |